Pilot clinical trial of an anti-TNF monoclonal antibody for the treatment of septic shock

Author： BOILLOT A CAPELLIER G RACADOT E WIJDENES J HERVE P BARALE F

ISSN： 0956-3075

Source： Clinical Intensive Care, Vol.6, Iss.2, 1995-04, pp. : 52-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia

Current Drug Therapy, Vol. 7, Iss. 4, 2012-12 ,pp. : 281-289

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical observations on the use of phosphodiesterase inhibitors as second-line inotropes in septic shock

By GRANT I S MACKENZIE S J

Clinical Intensive Care, Vol. 8, Iss. 1, 1997-02 ,pp. : 10-13

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Update on Anti-TNF-Alpha Treatment in Rheumatic Diseases

Current Drug Therapy, Vol. 1, Iss. 3, 2006-09 ,pp. : 311-318

Bentham Science Publishers

Access to resources Recommend Favorite

Prostacyclin for the treatment of hepatic failure after resolution of septic shock

By REINELT H EICHELBRÖNNER O MESZÖDY M GEORGIEFF M RADERMACHER P

Clinical Intensive Care, Vol. 6, Iss. 6, 1995-12 ,pp. : 290-290

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Safety of Anti-TNF Alpha Agents in the Pregnant Psoriatic Patient

Current Drug Therapy, Vol. 8, Iss. 1, 2013-03 ,pp. : 45-58

Bentham Science Publishers

Access to resources Recommend Favorite